MaxCyte Q2 Gross Profit USD 5.6 Million
MXCT•MaxCyte reports second-quarter results
Aug. 12 (Reuters) - MaxCyte Q2 net income USD -8.9 million.
- Q2 operating expenses USD 15.8 million
- Q2 revenue USD 7.3 million vs. IBES estimate USD 6.48 million
- Q2 cash & investments USD 141.9 million
- Q2 adjusted EBITDA USD -9.3 million vs. IBES estimate USD -8.93 million




